id: portal_hypertension_detection_to_surgical_eligibility_hcc
name: Portal Hypertension Detection and Management â†’ Surgical Eligibility for Hepatocellular
  Carcinoma
from_node:
  node_id: portal_hypertension_detection
  node_name: Portal Hypertension Detection and Management
to_node:
  node_id: surgical_eligibility_hcc
  node_name: Surgical Eligibility for Hepatocellular Carcinoma
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Portal hypertension status is a critical determinant of surgical eligibility
  and post-operative complication risk'
- 'Step 2: Access to diagnostic procedures (hepatic venous pressure gradient measurement,
  imaging) required to assess portal hypertension varies by healthcare setting'
- 'Step 3: Lack of portal hypertension assessment may lead to inappropriate treatment
  selection or missed opportunities for optimal intervention'
- 'Step 4: Healthcare infrastructure determines whether comprehensive pre-treatment
  evaluation including portal hypertension assessment is standard of care'
evidence:
  quality_rating: C
  n_studies: 18
  primary_citation: 'Avik Majumdar et al. 2017. "Management of people with early-
    or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.."
    *The Cochrane database of systematic reviews*. https://doi.org/10.1002/14651858.CD011650.pub2'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.641959'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: cirrhosis_prevalence
  direction: strengthens
  strength: strong
  description: In populations with high cirrhosis prevalence, portal hypertension
    assessment becomes more critical for treatment planning
- name: specialist_gastroenterology_access
  direction: strengthens
  strength: moderate
  description: Access to hepatology specialists who can perform and interpret portal
    hypertension diagnostics structures treatment eligibility determinations
